He is also director of the Laboratory of Molecular Neurobiology and Neuroproteomics. His research interests include the structural basis of amyloid-associated toxicity in neurodegenerative disease, developing tools to monitor and control protein misfolding and aggregation in vivo, developing cellular models of neurodegeneration, and treating disease by modifying protein aggregation and clearance.